NUVB
Nuvation Bio Inc
NYSE: NUVB · HEALTHCARE · BIOTECHNOLOGY
$4.34
-4.82% today
Updated 2026-04-29
Market cap
$1.51B
P/E ratio
—
P/S ratio
23.99x
EPS (TTM)
$-0.60
Dividend yield
—
52W range
$2 – $10
Volume
4.2M
Nuvation Bio Inc (NUVB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $158000.00 | $120.95M | $221.79M | $776.15M | $672.14M | $621.48M | $540.63M |
| Cash & equivalents | $138000.00 | $3.47M | $29.75M | $132.42M | $101.10M | $42.65M | $35.72M |
| Current assets | $158000.00 | $119.89M | $220.68M | $772.07M | $667.32M | $616.43M | $526.25M |
| Total liabilities | $902000.00 | $3.20M | $6.71M | $30.15M | $17.07M | $16.36M | $76.84M |
| Current liabilities | $902000.00 | $3.20M | $6.55M | $16.93M | $13.16M | $13.97M | $58.24M |
| Long-term debt | — | — | — | — | — | — | — |
| Shareholder equity | $-744000.00 | $117.75M | $215.08M | $746.00M | $655.08M | $605.12M | $463.79M |
| Retained earnings | $-744000.00 | $-34.30M | $-75.95M | $-162.80M | $-267.00M | $-342.80M | $-910.74M |
| Accounts receivable | — | $828000.00 | $1.09M | $3.04M | $2.48M | $3.70M | $16.29M |
| Inventory | — | — | $2.92M | $643.08M | — | — | — |
| Goodwill | — | — | — | — | — | — | — |